FITLIFE BRANDS, INC.
Close on Oct 19, 2026
- Market cap
- $81.53M
- P/E (TTM)
- 43.3
- Dividend yield
- –
About Fitlife Brands
Medicinal Chemicals & Botanical Products, SIC 2833
FitLife Brands, Inc. develops, markets, and distributes nutritional supplements and wellness formulations. Its offerings span sports nutrition, weight loss, total body wellness, energy, natural skincare, and male health products. The company organizes its product lines under various brand families, including NDS Products, iSatori Products, MRC Products, MusclePharm, and Irwin Products. These items serve athletes, active individuals, and health-conscious consumers through e-commerce channels, wholesale distributors, mass merchandisers, health food shops, and specialty retailers.
The company operates primarily across the United States and serves international markets, including retail distribution in Canada and product registrations in Europe. Distribution encompasses more than 1,900 domestic franchise and corporate GNC locations as well as major retail partners such as Walmart, CVS, Walgreens, and Costco Canada. FitLife Brands is headquartered in Omaha, Nebraska, and contracts with third-party manufacturers located within the United States.
Summary of the business section of Fitlife Brands's latest annual report, written by StockData.
Company profile
Company
- Legal name
- FITLIFE BRANDS, INC.
- Founded
- 1994
- Headquarters
- Omaha, NE
- Address
- 5214 S. 136th Street 68137
- Phone
- (402) 884-1894
- Website
- fitlifebrands.com
- Employees
- 39, Dec 31, 2025
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Weinberg & Company, P.A., Los Angeles, California
Stock & identifiers
- Ticker
- FTLF
- Exchange
- Nasdaq
- Shares outstanding
- 9M, Aug 12, 2026
- Public float
- $50.75M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 2-for-1, Feb 7, 2025; 2-for-1, Feb 7, 2025; 4-for-1, Dec 8, 2021; 4-for-1, Dec 2, 2021; 1-for-10 reverse, May 15, 2019; 1-for-10 reverse, Sep 30, 2013
- SEC CIK
- 1374328
- CUSIP
- 33817P405
- ISIN
- US33817P4054
- LEI
- 549300A8X02SIUSI3V40
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Judd Dayton | CHIEF EXECUTIVE OFFICER, Director | 5,288,658 |
| Jakob York | CHIEF FINANCIAL OFFICER | 3,484 |
| Ryan P. Hansen | President | 25,678 |
| Shannon K. Pappas | Director | 1,000 |
| Seth Yakatan | Director | 429 |
| Matthew Lingenbrink | Director | 8,800 |
| Grant Robert Dawson | Director | 158,000 |
| Todd Ordal | Director | 62,488 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $598.77K | $598.77K | $332.41K | $204 | – |
| FY2024 | $578.00K | $634.60K | $299.82K | $204 | – |
| FY2023 | $532.00K | $637.12K | $282.71K | $119 | – |
| FY2022 | $475.46K | $411.02K | $241.53K | $100 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“We had 81 and 39 full-time employees as of December 31, 2025 and 2024, respectively, the increase in which is principally attributable to the acquisition of Irwin.”
Corporate history
Events identified from SEC filings